EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study

Maura Rosane Valerio Ikoma-Colturato iD, Felipe Magalhães Furtado, Camila Marques Bertolucci, Alef Rafael Severino, Elizabeth Xisto Souto, Tharsis Cardoso Ferreira Dos Santos, Ana Paula Fortunato Dametto, Miriam Perlingeiro Beltrame, Nydia Strachman Bacal, Danielle Marchetti Vitelli Avelar, Raquel Arrieche Fernandes, Bernadete Evangelho Gomes und 12 weitere

eJHaem · 2025-10 · 6 (5)

DOI: 10.1002/jha2.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 14.10.2025. Verfasst von Maura Rosane Valerio Ikoma-Colturato und 23 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Amaral Carvalho Jaú São Paulo Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer, BD, Pfizer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Measurable residual disease (MRD) is a strong predictor of the risk of relapse of acute myeloid leukemia (AML). Therefore, for use in clinical decision‐making, methods for MRD assessment must achieve adequate accuracy, sensitivity, specificity, and reproducibility. Multiparametric flow cytometry (MFC) is the most widely used method for assessing AML‐MRD, but its sensitivity varies considerably due to the differing approaches used across centers, in addition to the different experiences of flow cytometrists, especially during clonal evolution. This study aimed to standardize AML‐MRD by MFC in a multicenter project involving 16 Brazilian laboratories.

Methods

In the first phase, specialists were trained in pre‐analytical standard operating procedures (SOPs) and analysis strategies of pre‐validated 8‐ and 10‐color protocols, followed by a data‐only, that is, a Dry Phase of flow cytometry standard (FCS) file exchange by the coordinating laboratory in a comparability assessment. In the second or Wet Phase, laboratories prepared and analyzed their samples, and the FCS files were submitted for central analysis.

Results

The agreement of MRD results was 81% and 80% between laboratories and central analysts in the Dry and Wet Phases, respectively. However, non‐suitable application of pre‐analytical SOPs hampered MRD interpretation for 30% of the laboratories in the Wet Phase.

Conclusions

This study demonstrated that standardized flow cytometry protocols are reproducible as long as rigorous SOPs are implemented. The project's results underscore that continuous education and external quality control are essential to build expertise and ensure reliable AML‐MRD results in clinical practice. Trial Registration :The authors have confirmed clinical trial registration is not needed for this submission.

Schlagwörter

Stichwörter der Autor:innen

acute myeloid leukemiaflow cytometrymeasurable residual diseasestandardization

Autor:innen und Institutionen

  • Hospital Amaral Carvalho Jaú São Paulo Brazil.
  • Sabin Medicina Diagnóstica Brasília Brazil.
  • Hospital Da Criança de Brasília José Alencar Brasília >Distrito Federal Brazil.
  • Hospital De Cancer de Barretos São Paulo Brazil.
  • Hemocentro de São José do Rio Preto São Paulo Brazil.
  • Sollutio Diagnósticos Indaiatuba São Paulo Brazil.

ORCID-Profile: Maura Rosane Valerio Ikoma-Colturato

Förderung

  • Pfizer
  • BD
  • Pfizer Foundation

Zitieren

APA

Ikoma-Colturato, M. R. V., Magalhães Furtado, F., Bertolucci, C. M., Severino, A. R., Souto, E. X., Ferreira Dos Santos, T. C., Dametto, A. P. F., Beltrame, M. P., Bacal, N. S., Avelar, D. M. V., Fernandes, R. A., Gomes, B. E., da Costa, E. S., Santos, B. E. F. D. S., Mendonça de Pontes, R., Périco, M. D. H., Gevert, F., de Siqueira, P. F. R., Marquezotti, F., …, & Vigorito, A. C. (2025). Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study. eJHaem, 6(5). https://doi.org/10.1002/jha2.70163

Vancouver

Ikoma-Colturato MRV, Magalhães Furtado F, Bertolucci CM, Severino AR, Souto EX, Ferreira Dos Santos TC, et al. Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study. eJHaem. 2025;6(5). doi:10.1002/jha2.70163

BibTeX
@article{IkomaColturato2025,
  author = {Ikoma-Colturato, Maura Rosane Valerio and Magalhães Furtado, Felipe and Bertolucci, Camila Marques and Severino, Alef Rafael and Souto, Elizabeth Xisto and Ferreira Dos Santos, Tharsis Cardoso and Dametto, Ana Paula Fortunato and Beltrame, Miriam Perlingeiro and Bacal, Nydia Strachman and Avelar, Danielle Marchetti Vitelli and Fernandes, Raquel Arrieche and Gomes, Bernadete Evangelho and da Costa, Elaine Sobral and Santos, Berta Elisa Fonseca da Silva and Mendonça de Pontes, Robéria and Périco, Maria Daniela Holthausen and Gevert, Fabíola and de Siqueira, Patrícia Fernanda Rosa and Marquezotti, Fernanda and Wagner, Andressa Oliveira Martin and Soares, Ana Claudia Carramaschi Villela and Duarte, Fernando Barroso and Flowers, Mary Evelyn and Vigorito, Afonso Celso},
  title = {Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study},
  journal = {eJHaem},
  year = {2025},
  volume = {6},
  number = {5},
  doi = {10.1002/jha2.70163}
}
Kostenlos starten →